Front. Stroke Frontiers in Stroke Front. Stroke 2813-3056 Frontiers Media S.A. 10.3389/fstro.2024.1371734 Stroke Correction Corrigendum: Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke Fisher Elizabeth S. 1 † Chen Yanan 1 † Sifuentes Mikaela M. 1 † Stubblefield Jeremy J. 1 Lozano Damian 1 Holstein Deborah M. 1 Ren JingMei 2 Davenport Matthew 2 DeRosa Nicholas 1 Chen Tsung-pei 1 Nickel Gerard 1 Liston Theodore E. 3 Lechleiter James D. 1 * 1Department of Cell Systems and Anatomy, University of Texas Health at San Antonio, San Antonio, TX, United States 2NeuroVasc Preclinical Services, Inc., Lexington, MA, United States 3Astrocyte Pharmaceuticals Inc., Cambridge, MA, United States

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: James D. Lechleiter lechleiter@uthscsa.edu

†These authors share first authorship

 29 01 2024 2024 3 1371734 16 01 2024 18 01 2024 Copyright © 2024 Fisher, Chen, Sifuentes, Stubblefield, Lozano, Holstein, Ren, Davenport, DeRosa, Chen, Nickel, Liston and Lechleiter. 2024 Fisher, Chen, Sifuentes, Stubblefield, Lozano, Holstein, Ren, Davenport, DeRosa, Chen, Nickel, Liston and Lechleiter

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke by Fisher, E. S., Chen, Y., Sifuentes, M. M., Stubblefield, J. J., Lozano, D., Holstein, D. M., Ren, J., Davenport, M., DeRosa, N., Chen, T. -p., Nickel, G., Liston, T. E., and Lechleiter, J. D. (2022). Front. Stroke 1:1010928. doi: 10.3389/fstro.2022.1010928 Adora3 stroke treatment mitochondrial metabolism ATP astrocytes section-at-acceptance Acute Stroke and Interventional Therapies

In the published article, there was an error in the Funding statement. The funding source for coauthor Jeremy J. Stubblefield was not included. Original text: This study received funding from Astrocyte Pharmaceuticals, Inc. The correct Funding statement appears below.

Funding

This study received funding from Astrocyte Pharmaceuticals, Inc. JS was supported by NIH IRACDA training grant K12 GM111726.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

 Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.